143 related articles for article (PubMed ID: 35304400)
1. Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study.
Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Kahn SE; Danaei G; Boyko EJ
BMJ Open; 2022 Mar; 12(3):e058363. PubMed ID: 35304400
[TBL] [Abstract][Full Text] [Related]
2. Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces.
McAlister FA; Wang T; Wang X; Chu A; Goodman SG; van Diepen S; Jackevicius CA; Kaul P; Udell J; Ko DT; Kwong JC; Austin PC; Lee DS;
J Am Heart Assoc; 2021 Nov; 10(21):e022330. PubMed ID: 34689613
[TBL] [Abstract][Full Text] [Related]
3. Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.
Hunt CM; Efird JT; Redding TS; Thompson AD; Press AM; Williams CD; Hostler CJ; Suzuki A
J Gen Intern Med; 2022 Dec; 37(16):4144-4152. PubMed ID: 35768681
[TBL] [Abstract][Full Text] [Related]
4. Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner.
Rivera AS; Al-Heeti O; Petito LC; Feinstein MJ; Achenbach CJ; Williams J; Taiwo B
BMC Infect Dis; 2023 Feb; 23(1):115. PubMed ID: 36829115
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19.
Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Young BA; Boyko EJ
BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34083248
[TBL] [Abstract][Full Text] [Related]
6. All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study.
El-Solh AA; Lawson Y; El-Solh DA
Intern Emerg Med; 2022 Apr; 17(3):685-694. PubMed ID: 34637080
[TBL] [Abstract][Full Text] [Related]
7. Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies.
Lee SW; Kim SY; Moon SY; Yoo IK; Yoo EG; Eom GH; Kim JM; Shin JI; Jeong MH; Yang JM; Yon DK
JMIR Public Health Surveill; 2021 Oct; 7(10):e29379. PubMed ID: 34623311
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs.
Cai M; Bowe B; Xie Y; Al-Aly Z
BMJ Open; 2021 Aug; 11(8):e047369. PubMed ID: 34400452
[TBL] [Abstract][Full Text] [Related]
9. Association of Perioperative Statin Use With Mortality and Morbidity After Major Noncardiac Surgery.
London MJ; Schwartz GG; Hur K; Henderson WG
JAMA Intern Med; 2017 Feb; 177(2):231-242. PubMed ID: 27992624
[TBL] [Abstract][Full Text] [Related]
10. Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Memel ZN; Lee JJ; Foulkes AS; Chung RT; Thaweethai T; Bloom PP
J Infect Dis; 2022 Jan; 225(1):19-29. PubMed ID: 34665852
[TBL] [Abstract][Full Text] [Related]
11. Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia.
Piani F; Di Salvo E; Landolfo M; Saracino IM; Agnoletti D; Borghi C; Fiorini G
Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):227-231. PubMed ID: 36411214
[TBL] [Abstract][Full Text] [Related]
12. Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.
Wander PL; Lowy E; Beste LA; Tulloch-Palomino L; Korpak A; Peterson AC; Kahn SE; Boyko EJ
Diabetes Care; 2021 Dec; 44(12):2708-2713. PubMed ID: 34615690
[TBL] [Abstract][Full Text] [Related]
13. Differences in COVID-19-Related Testing and Healthcare Utilization by Race and Ethnicity in the Veterans Health Administration.
Razjouyan J; Helmer DA; Li A; Naik AD; Amos CI; Bandi V; Sharafkhaneh A
J Racial Ethn Health Disparities; 2022 Apr; 9(2):519-526. PubMed ID: 33694124
[TBL] [Abstract][Full Text] [Related]
14. Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19.
Izkhakov E; Vilian Y; Buch A; Denysov V; Namouz D; Nathan A; Greenman Y; Ziv-Baran T
BMC Geriatr; 2023 Aug; 23(1):473. PubMed ID: 37550638
[TBL] [Abstract][Full Text] [Related]
15. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
16. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
17. Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.
Cariou B; Goronflot T; Rimbert A; Boullu S; Le May C; Moulin P; Pichelin M; Potier L; Smati S; Sultan A; Tramunt B; Wargny M; Gourdy P; Hadjadj S;
Diabetes Metab; 2021 Mar; 47(2):101202. PubMed ID: 33091555
[TBL] [Abstract][Full Text] [Related]
18. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients.
Masana L; Correig E; Rodríguez-Borjabad C; Anoro E; Arroyo JA; Jericó C; Pedragosa A; Miret M; Näf S; Pardo A; Perea V; Pérez-Bernalte R; Plana N; Ramírez-Montesinos R; Royuela M; Soler C; Urquizu-Padilla M; Zamora A; Pedro-Botet J
Eur Heart J Cardiovasc Pharmacother; 2022 Feb; 8(2):157-164. PubMed ID: 33135047
[TBL] [Abstract][Full Text] [Related]
19. The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.
Chow R; Im J; Chiu N; Chiu L; Aggarwal R; Lee J; Choi YG; Prsic EH; Shin HJ
PLoS One; 2021; 16(6):e0253576. PubMed ID: 34166458
[TBL] [Abstract][Full Text] [Related]
20. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Al Harbi S; Al Shaya A; Badreldin HA; Kensara R; Alharthi AF; Alghamdi J; Alawad A; Alotaibi R; Kharbosh A; Al Muqati H; Alhuwahmel A; Almusallam M; Albarrak G; Al Sulaihim I; Alanazi B; Al-Dosari BS; Vishwakarma R; Alsaeedi AS; Al Ghamdi G; Alkofide H; Al-Dorzi HM
Front Public Health; 2022; 10():877944. PubMed ID: 36033795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
